This study is looking at the effects of an experimental drug in pediatric patients with relapsed leukemia.
Phase 2 study of inotuzumab ozogamicin in children and young adults with relapsed or refractory cd22+b acute lymphoblastic leukemia
Campus Maps / Parking
2500 North State Street
Jackson, MS 39216
General Information: 601-984-1000
Patient Appointments: 888-815-2005